EPISODE · Apr 28, 2026 · 34 MIN
GLP-1 Drugs Like Ozempic — How They Work and What Nobody Is Telling You About the Risks
from Unapologetically Significant · host Rich and Shelley Marie
GLP-1 receptor agonists — the class of drugs that includes Ozempic, Wegovy and Mounjaro — are being prescribed at unprecedented rates for weight loss and blood sugar management. But how do they actually work inside your body? And what are the long term risks that are not making headlines?In this episode we break down the science behind GLP-1 drugs, explain what glucagon-like peptide-1 actually does in your digestive system, and have an honest conversation about what happens when you override your body's natural metabolic signaling with pharmaceutical intervention.This is not an anti-medication episode. It is an informed conversation about what these drugs do, what they do not do, and what you need to understand before making a decision that affects your entire digestive system.In this episode we cover:What GLP-1 is and its natural role in digestion and metabolismHow GLP-1 receptor agonist drugs work mechanicallyThe documented side effects and long term risksWhat happens to digestion and gut motility on these medicationsThe Ayurvedic perspective on metabolic health and appetite regulationNatural ways to support GLP-1 function through whole food nutritionAn informed decision is always better than a popular one.Hosted by a board-certified Ayurvedic practitioner and chemical engineer and a certified nutritionist and Ayurvedic chef.New episode every Friday.
Embed this episode
NOW PLAYING
GLP-1 Drugs Like Ozempic — How They Work and What Nobody Is Telling You About the Risks
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.